Serinex Medical is a medical device and manufacturing company focused on advancing advanced wound care products for pressure ulcer prevention. The company is developing DuraDerma, a topical medical device designed to help protect vulnerable skin by preventing the progression of early-stage pressure ulcers in critical care and long-term care settings.

There are over 2.5 millions pressure injuries in the U.S. every year. Serinex's core mission is to address major unmet needs in hospitals, skilled nursing facilities, long-term care environments, and post-acute settings, where pressure injuries remain a significant source of patient harm, operational burden, and cost.

By focusing on practical, scalable solutions for clinicians and caregivers, Serinex aims to improve outcomes in pressure injury management, hospital-acquired pressure injury reduction, and patient skin integrity support. The company’s development strategy emphasizes strong regulatory planning, manufacturing readiness, clinical validation, and commercialization partnerships to bring differentiated products to market efficiently.

With a commitment to science-driven product development and real-world healthcare impact, Serinex is building a platform in medical technology, wound care innovation, and pressure ulcer prevention that supports providers, health systems, and care organizations working to reduce preventable skin damage and improve standards of care.

Serinex Medical

Org chart

Teams

Offices